Nalaganje...

Weekly versus tri‐weekly paclitaxel with carboplatin for first‐line treatment in women with ovarian cancer

This is the protocol for a review and there is no abstract. The objectives are as follows: To compare the effectiveness and safety of weekly paclitaxel with that of three‐weekly paclitaxel, in combination with carboplatin, as first‐line chemotherapy treatment for ovarian cancer.

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cochrane Database Syst Rev
Main Authors: Syn, Nicholas LX, Goh, Robby M, Goh, Boon Cher, Soon, Yu Yang, Tan, David SP
Format: Artigo
Jezik:Inglês
Izdano: John Wiley & Sons, Ltd 2015
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6457624/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012007
Oznake: Označite
Brez oznak, prvi označite!